XML 29 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities    
Net income $ 249.7 $ 206.6
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 20.6 19.1
Amortization of right-of-use-assets 5.7  
Stock-based compensation (Note 10) 20.8 18.4
Change in fair value of contingent consideration liabilities, net (Note 8) 6.7 3.8
Deferred income taxes 5.8 (15.5)
Purchase of intellectual property (Note 5) 24.0 0.0
Other (7.0) 1.0
Changes in operating assets and liabilities:    
Accounts and other receivables, net (45.8) 27.4
Inventories (29.4) (3.3)
Accounts payable and accrued liabilities (242.2) (115.5)
Income taxes (16.3) 39.9
Prepaid expenses and other current assets 2.8 (26.4)
Other 6.1 (4.2)
Net cash provided by operating activities 1.5 151.3
Cash flows from investing activities    
Capital expenditures (42.2) (43.2)
Purchases of held-to-maturity investments (Note 6) (30.0) 0.0
Proceeds from held-to-maturity investments (Note 6) 20.0 238.5
Proceeds from available-for-sale investments (Note 6) 56.1 42.3
Investments in intangible assets (16.8) (3.0)
Investments in trading securities, net (1.9) (3.1)
Investments in unconsolidated affiliates, net (Note 6) (1.3) (1.8)
Payment of contingent consideration 0.0 (10.0)
Payment for acquisition option (35.0) 0.0
Other 1.6 0.6
Net cash (used in) provided by investing activities (49.5) 220.3
Cash flows from financing activities    
Proceeds from issuance of debt, net 3.7 5.1
Payments on debt and capital lease obligations (4.0) (5.1)
Purchases of treasury stock (5.7) (2.1)
Proceeds from stock plans 45.0 44.8
Other 5.4 (1.8)
Net cash provided by financing activities 44.4 40.9
Effect of currency exchange rate changes on cash and cash equivalents (1.3) (3.8)
Net (decrease) increase in cash and cash equivalents (4.9) 408.7
Cash and cash equivalents at beginning of period 714.1 818.3
Cash and cash equivalents at end of period $ 709.2 $ 1,227.0